Xialla
Xialla lets men treat erectile dysfunction without a prescription by slowing blood outflow (veinous leakage) that causes ED in 55% of men.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Ottawa, ON, Canada
- Currency CAD
- Founded March 2019
- Employees 2
- Incorporation Type C-corp
- Website xialla.com
Company Summary
Xialla invented, develops and markets a new medical device that treats erectile dysfunction without a prescription, and without the risk or cost of drugs. Unlike conventional ED therapies that promote blood inflow, Xialla slows blood outflow that causes ED for 55% of men. Our business model is online direct sales/subscriptions and urologist channel partnerships. Our products are Xialla and consumable (repeat sales) adhesive pad refill packs.
Team
Advisors
-
Dane BedwardUnconfirmedMoe AbbasUnconfirmed
Previous Investors
-
Koby SmutyloUnconfirmed
-
Moe AbbasUnconfirmedMike HarkinsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.